Key result
ACE inhibitors improve HF survival whereas traditional diuretics and inotropes lack proven mortality benefit.
Why the study?
Congestive heart failure involves complex peripheral and cardiac abnormalities contributing to progression, with varying evidence on mortality effects of pharmacologic treatments.
What is the role of various pharmacologic therapies in the management and survival of patients with congestive heart failure?
Population
Patients with congestive heart failure
Comparison
Various pharmacologic treatments including ACE inhibitors, diuretics, vasodilators, inotropes, and beta-blockers
Design
Review
Authors
Loading...
Supports ACE inhibitors as standard HF therapy; leaves open mortality effects of diuretics and inotropes.
What is the role of various pharmacologic therapies in the management and survival of patients with congestive heart failure?
This review highlights the foundational role of ACE inhibitors in improving survival in heart failure, contrasting with the controversial or negative mortality effects of traditional inotropes.
Peter E. Carson (1996) conducted a review in Congestive heart failure. Pharmacologic treatment (ACE inhibitors, diuretics, vasodilators, inotropes, beta-blockers) was evaluated. ACE inhibitors improve survival and are standard therapy for heart failure, whereas traditional diuretics and most inotropic agents lack convincing mortality reduction data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: